FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2805259160> ?p ?o ?g. }

• W2805259160 endingPage "e000206" @default.
• W2805259160 startingPage "e000206" @default.
• W2805259160 abstract "The medical treatment options for patients with Crohn's disease (CD) are limited and patients resistant to those therapies are left requiring surgical operations that usually only achieve some symptomatic relief. Mesenchymal stem cells (MSC) have been shown to be effective for the treatment of CD, and we have demonstrated in animal experiments that human amnion-derived MSCs (AMSC) are a potential new therapeutic strategy. Therefore, we designed this study to investigate the safety and efficacy of AMSCs in patients with treatment-resistant CD.This is the protocol for an ongoing phase I/II, dual-centre, open-label, uncontrolled, dose-response study. The estimated enrolment is 6-12 patients with treatment-resistant, moderate CD. A dose of 1.0×106 cells/kg will be administered intravenously in the low-dose group at days 0 and 7. After confirming the safety of low-dose administration, a dose of 4.0×106 cells/kg will be administered intravenously in the high-dose group on days 0 and 7. The primary endpoint will measure the occurrence of adverse events related to acute infusion toxicity, and secondary endpoints will include long-term adverse events and efficacy of AMSC administration.The Institutional Review Board of Hokkaido University Hospital approved this study protocol (approval number H29-6). A report releasing study results will be submitted to an appropriate journal.This study is the first to investigate the safety and efficacy of AMSC use for CD treatment. Our results will advance studies on more efficient and convenient methods to overcome the limits of available CD treatments.UMIN000029841." @default.
• W2805259160 created "2018-06-13" @default.
• W2805259160 creator A5014031939 @default.
• W2805259160 creator A5015906898 @default.
• W2805259160 creator A5022230206 @default.
• W2805259160 creator A5024713150 @default.
• W2805259160 creator A5031075524 @default.
• W2805259160 creator A5048319142 @default.
• W2805259160 creator A5051053241 @default.
• W2805259160 creator A5056569530 @default.
• W2805259160 creator A5062739693 @default.
• W2805259160 creator A5078000437 @default.
• W2805259160 creator A5078843127 @default.
• W2805259160 creator A5081770697 @default.
• W2805259160 creator A5082147317 @default.
• W2805259160 creator A5086655999 @default.
• W2805259160 date "2018-05-01" @default.
• W2805259160 modified "2023-10-03" @default.
• W2805259160 title "Evaluation of amnion-derived mesenchymal stem cells for treatment-resistant moderate Crohn’s disease: study protocol for a phase I/II, dual-centre, open-label, uncontrolled, dose–response trial" @default.
• W2805259160 cites W1975451397 @default.
• W2805259160 cites W1992035731 @default.
• W2805259160 cites W2065491856 @default.
• W2805259160 cites W2077531651 @default.
• W2805259160 cites W2086636575 @default.
• W2805259160 cites W2088826436 @default.
• W2805259160 cites W2102087425 @default.
• W2805259160 cites W2105734762 @default.
• W2805259160 cites W2106160422 @default.
• W2805259160 cites W2115499099 @default.
• W2805259160 cites W2132674593 @default.
• W2805259160 cites W2160666118 @default.
• W2805259160 cites W2283559094 @default.
• W2805259160 cites W2584451453 @default.
• W2805259160 cites W2586312403 @default.
• W2805259160 cites W2735988666 @default.
• W2805259160 cites W2765979567 @default.
• W2805259160 cites W301897234 @default.
• W2805259160 cites W4233817719 @default.
• W2805259160 doi "https://doi.org/10.1136/bmjgast-2018-000206" @default.
• W2805259160 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6001910" @default.
• W2805259160 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29915666" @default.
• W2805259160 hasPublicationYear "2018" @default.
• W2805259160 type Work @default.
• W2805259160 sameAs 2805259160 @default.
• W2805259160 citedByCount "10" @default.
• W2805259160 countsByYear W28052591602018 @default.
• W2805259160 countsByYear W28052591602019 @default.
• W2805259160 countsByYear W28052591602021 @default.
• W2805259160 countsByYear W28052591602022 @default.
• W2805259160 countsByYear W28052591602023 @default.
• W2805259160 crossrefType "journal-article" @default.
• W2805259160 hasAuthorship W2805259160A5014031939 @default.
• W2805259160 hasAuthorship W2805259160A5015906898 @default.
• W2805259160 hasAuthorship W2805259160A5022230206 @default.
• W2805259160 hasAuthorship W2805259160A5024713150 @default.
• W2805259160 hasAuthorship W2805259160A5031075524 @default.
• W2805259160 hasAuthorship W2805259160A5048319142 @default.
• W2805259160 hasAuthorship W2805259160A5051053241 @default.
• W2805259160 hasAuthorship W2805259160A5056569530 @default.
• W2805259160 hasAuthorship W2805259160A5062739693 @default.
• W2805259160 hasAuthorship W2805259160A5078000437 @default.
• W2805259160 hasAuthorship W2805259160A5078843127 @default.
• W2805259160 hasAuthorship W2805259160A5081770697 @default.
• W2805259160 hasAuthorship W2805259160A5082147317 @default.
• W2805259160 hasAuthorship W2805259160A5086655999 @default.
• W2805259160 hasBestOaLocation W28052591601 @default.
• W2805259160 hasConcept C126322002 @default.
• W2805259160 hasConcept C141071460 @default.
• W2805259160 hasConcept C142724271 @default.
• W2805259160 hasConcept C172680121 @default.
• W2805259160 hasConcept C197934379 @default.
• W2805259160 hasConcept C198826908 @default.
• W2805259160 hasConcept C203092338 @default.
• W2805259160 hasConcept C2779234561 @default.
• W2805259160 hasConcept C2780646683 @default.
• W2805259160 hasConcept C31760486 @default.
• W2805259160 hasConcept C535046627 @default.
• W2805259160 hasConcept C54355233 @default.
• W2805259160 hasConcept C71924100 @default.
• W2805259160 hasConcept C86803240 @default.
• W2805259160 hasConcept C98274493 @default.
• W2805259160 hasConceptScore W2805259160C126322002 @default.
• W2805259160 hasConceptScore W2805259160C141071460 @default.
• W2805259160 hasConceptScore W2805259160C142724271 @default.
• W2805259160 hasConceptScore W2805259160C172680121 @default.
• W2805259160 hasConceptScore W2805259160C197934379 @default.
• W2805259160 hasConceptScore W2805259160C198826908 @default.
• W2805259160 hasConceptScore W2805259160C203092338 @default.
• W2805259160 hasConceptScore W2805259160C2779234561 @default.
• W2805259160 hasConceptScore W2805259160C2780646683 @default.
• W2805259160 hasConceptScore W2805259160C31760486 @default.
• W2805259160 hasConceptScore W2805259160C535046627 @default.
• W2805259160 hasConceptScore W2805259160C54355233 @default.
• W2805259160 hasConceptScore W2805259160C71924100 @default.
• W2805259160 hasConceptScore W2805259160C86803240 @default.
• W2805259160 hasConceptScore W2805259160C98274493 @default.
• W2805259160 hasIssue "1" @default.
• W2805259160 hasLocation W28052591601 @default.

• next